TENESSA PINKERTON: Open Payments
NPI 1407374820 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 86 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $443 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $565 |
| Lilly USA, LLC | 5 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $158 |
| ABBVIE INC. | 15 | $147 |
| Phathom Pharmaceuticals, Inc. | 6 | $95 |
| GENZYME CORPORATION | 5 | $93 |
| Gilead Sciences, Inc. | 4 | $84 |
| Madrigal Pharmaceuticals | 2 | $68 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
Products named: TREMFYA, ENTYVIO, VOQUEZNA, DUPIXENT, CREON, OMVOH, REZDIFFRA, EOHILIA.
Industry payments across OK — which companies pay providers there.
